Feasibility Study of Physiotherapy for Functional Motor Symptoms

May 13, 2016 updated by: University College, London

Randomised Feasibility Study of a Physiotherapy Programme for Patients With Functional Motor Symptoms (FMS).

The aim of this study is to develop and assess the feasibility of a physiotherapy intervention for people with functional motor symptoms (also known as psychogenic neurological symptoms and conversion disorder). Participants will be randomised to receive the intervention or a "treatment as usual" control.

Study Overview

Status

Completed

Conditions

Detailed Description

Participants will be recruited from outpatient neurology clinics at Queen Square. Those who consent to take part will complete baseline outcome measures (Time 1) before being randomised to either a Treatment as Usual control group or the Intervention group.

Treatment as Usual group -

  1. Participants will be directed to online patient information resources (www.neurosymptoms.org)
  2. Participants will be placed on the waiting list to be assessed for the inpatient treatment programme for functional symptoms at The National Hospital for Neurology and Neurosurgery. The waitlist is currently greater than 12 months.
  3. A referral is made to local community therapy services (which may include physiotherapy, occupational therapy and psychological therapy). If the participant has had contact from their community therapy services in the previous 12 months, a letter summarising the participant's diagnosis and physiotherapy needs will be sent.
  4. Participants will be asked to return at 4 weeks to complete outcome measures for a second time (Time 2)

A referral to community therapy for such patients is usual practice in the UK, although the form in which the community therapy is provided tends to be inconsistent across the UK. In most cases it will entail between 1 and 8 outpatient or domiciliary physiotherapy appointments. Some communities will have access to Occupational Therapy, which may entail supported practice and advice to increase independence with functional tasks and the provision of equipment. The provision of community therapy to participants will be monitored through the CSRI.

Intervention Group -

For participants allocated to the intervention group, a 5 day admission on the Day Hospital at the National Hospital for Neurology and Neurosurgery is arranged. The physiotherapy intervention will take place in the physiotherapy department. Participants will be admitted individually (and not in groups). Outside of physiotherapy times participants are encouraged to rest in the day hospital and complete a workbook. A single independent physiotherapist will be trained to deliver the intervention.

The participant (+/- family member) will attend an initial meeting with the consultant neurologist and the treating physiotherapist. The neurologist will perform a brief neurological assessment and confirm the diagnosis.

  1. The diagnosis will be explained again to the patient, using the word "functional" to describe the diagnosis.
  2. Physical signs of FMS will be demonstrated to the patient. This includes distractibility, Hoover's sign and entrainment.
  3. The treatment programme will be explained to the patient, linking resolution of symptoms with treatment rationale.
  4. The participant will attend 8-9 physiotherapy sessions over the 5 days. The intervention is a combination of education on functional motor symptoms, movement retraining and development of a self management plan.
  5. After the final physiotherapy session, the participant will complete the outcome measures (Time 2) and a feedback form.

Both groups will be followed up at 6 months after recruitment to the study (Time 3). An independent assessor will administer the outcome measures.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • London, United Kingdom, WC1N 3BG
        • The National Hospital for Neurology and Neurosurgery

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • A clinically established diagnosis of functional motor symptoms according to the Fahn-Williams criteria.
  • Diagnostic investigations have come to an end.
  • The patient accepts the diagnosis of functional motor symptoms.
  • Symptom duration of at least six months.
  • Symptoms must be sufficient to cause significant distress (subjectively described by the patient) or impairment in social, occupational or other important areas of functioning.

Exclusion Criteria:

  • Unable to understand English.
  • Pain, fatigue or dissociative seizures is the predominant symptom.
  • Prominent untreated axis 1 disorders (e.g. anxiety or depression).
  • Level of disability prevents participation in a 5 day outpatient programme (Barthel Index score less than 25/100)
  • Patient unable to attend 5 consecutive days.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
5 Day physiotherapy programme at the National Hospital for Neurology and Neurosurgery, Queen Square, London UK.
The experimental group will complete a 5 day physiotherapy programme consisting of education, movement retraining and a self management plan.
Active Comparator: Treatment as usual
Participants are referred to their local neuro-physiotherapy service and if appropriate placed on a waiting list for inpatient rehabilitation.
Treatment as usual physiotherapy. The participant will be referred to their closest NHS outpatient neuro-physiotherapy service.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Global Impression Scale of Change
Time Frame: Approximately 4 weeks after randomisation (this will be immediately after treatment for the experimental arm) and 6 months
Self rated 5 point Likert scale of change
Approximately 4 weeks after randomisation (this will be immediately after treatment for the experimental arm) and 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Short Form 36
Time Frame: Baseline and 6 months
Baseline and 6 months
Hospital Anxiety and Depression Scale
Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months
Baseline, approximately 4 weeks after randomisation and 6 months
EQ-5D-5L
Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months
Baseline, approximately 4 weeks after randomisation and 6 months
Brief Illness Perception Questionnaire
Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months
Baseline, approximately 4 weeks after randomisation and 6 months
Work and Social Adjustment Scale
Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months
Baseline, approximately 4 weeks after randomisation and 6 months
Disabilities of the Arm, Shoulder and Hand (DASH)
Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months
self reported questionnaire of upper limb function
Baseline, approximately 4 weeks after randomisation and 6 months
Functional Mobility Scale
Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months
Scale of assistance required when walking 5, 50 and 500 metres.
Baseline, approximately 4 weeks after randomisation and 6 months
Psychogenic Movement Disorders Rating Scale (PMDRS)
Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months
Blind video analysis of movement
Baseline, approximately 4 weeks after randomisation and 6 months
Berg Balance Scale
Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months
Baseline, approximately 4 weeks after randomisation and 6 months
10 metre Walk Test
Time Frame: Baseline, approximately 4 weeks after randomisation and 6 months
timed walk over 10 metres
Baseline, approximately 4 weeks after randomisation and 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Client Services Receipt Inventory (CSRI)
Time Frame: Baseline and 6 month follow up
This questionnaire collects retrospective information about the use of health and social care services, income, employment and benefits. It can be used to calculate service costs and total costs of care.
Baseline and 6 month follow up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Glenn Nielsen, UCL

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2014

Primary Completion (Actual)

January 1, 2016

Study Completion (Actual)

January 1, 2016

Study Registration Dates

First Submitted

October 20, 2014

First Submitted That Met QC Criteria

October 22, 2014

First Posted (Estimate)

October 27, 2014

Study Record Updates

Last Update Posted (Estimate)

May 16, 2016

Last Update Submitted That Met QC Criteria

May 13, 2016

Last Verified

May 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Conversion Disorder

Clinical Trials on 5 Day Physiotherapy Programme

Subscribe